Viral Platform Growth VirusExpress lentiviral production platform expands MilliporeSigma's viral vector manufacturing capabilities for gene therapy clients. Ongoing Carlsbad facility expansion scales viral and gene therapy CDMO services, signaling strong outsourcing demand. Target buyers include biotech startups and mid-sized pharma seeking end-to-end viral vector development and GMP manufacturing.

Sustainability Leadership Leadership in sustainability is demonstrated by the 2026 Environment+Energy Leader Spotlight Award and the launch of supplier Sustainability Toolkits and a bio-based solvent portfolio for HPLC. This combination enables cross-sell of greener reagents, sustainable process development, and supply chain transparency to customers prioritizing responsible sourcing. Engage procurement and R&D teams with sustainability assessments, supplier programs, and environmental impact initiatives.

Integrated CDMO Advantage MilliporeSigma positions as one of the broadest biotech tool portfolios with a fully integrated CDMO and contract testing capability across traditional and novel modalities. This breadth enables cross-selling across development, manufacturing, analytics and regulatory support for pharma, biotech and academic customers. Ideal targets are organizations seeking an all-in-one partner for end-to-end development through commercial manufacturing.

Digital Platform Enablement Digital capabilities underpinning Snowplow, Salesforce and other tools reflect a focus on digital offerings and data driven workflows. Opportunity for sales includes integrated digital procurement, lab analytics, instrument management and automated data capture to streamline client operations. Position MilliporeSigma as a tech enabled partner for customers seeking seamless, end-to-end lab infrastructure.

Compliance Risk Regulatory scrutiny over unauthorised sale of hazardous chemicals highlights the importance of compliance, supplier vetting and product stewardship. There is an opportunity to offer compliance services, supplier qualification programs and training to help customers meet global regulations. Market segments in pharma development and manufacturing can benefit from risk mitigation solutions and trusted sourcing networks.